Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gudrun Ratzinger

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Plos One|June 20, 2025
Genomic profiling in hidradenitis suppurativa: InterOmics pipeline for DNA-RNA sequencing highlights HLA variants, keratin-associated mutations and extracellular matrix alterations as contributing factors to HS pathogenesisLucas André Cavalcanti Brandão, Ronald Rodrigues de Moura, Bruno Rodrigo Assunção, et al.
Archives of Dermatological Research|March 18, 2019
Successful intra-class switching among IL-17 antagonists: a multicentre, multinational, retrospective studyIrina Gasslitter, Natalia Kirsten, Matthias Augustin, et al.
The Journal of Allergy and Clinical Immunology|February 20, 2025
IL-36-driven pustulosis: Transcriptomic signatures match between generalized pustular psoriasis (GPP) and acute generalized exanthematous pustulosis (AGEP)Theresa Benezeder, Natalie Bordag, Johannes Woltsche, et al.
Nucleic Acids Research|January 15, 2021
Evidence for multi-copy Mega-NUMTs in the human genomeSabine Lutz-Bonengel, Harald Niederstätter, Jana Naue, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 16, 2025
Recommendations for the diagnostic work-up of cutaneous small vessel vasculitis - Position Statement of the European Academy of Dermatology and Venereology Vasculitis and Vasculopathy Task ForceErkan Alpsoy, Marzia Caproni, David A Wetter, et al.
The British Journal of Dermatology|October 12, 2025
Real-world evidence on palmoplantar pustulosis: patient characteristics, diagnostic challenges and predictive factors for treatment survival - a retrospective registry studyThomas Graier, Natalie Bordag, Wolfgang Weger, et al.
JAAD International|August 19, 2021
Effectiveness and clinical predictors of drug survival in psoriasis patients receiving apremilast: A registry analysisThomas Graier, Wolfgang Weger, Paul-Gunther Sator, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 12, 2023
Entwicklung der Patientencharakteristika und der Wirksamkeit der Biologika-Therapie bei Patienten des Österreichischen Psoriasis-Registers von 2004 bis 2022Thomas Graier, Wolfgang Salmhofer, Constanze Jonak, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 31, 2023
Evolution of characteristics and biologic treatment effectiveness in patients of the Austrian psoriasis registry from 2004-2022Thomas Graier, Wolfgang Salmhofer, Constanze Jonak, et al.
Acta Dermato-Venereologica|August 14, 2015
Survival and Effectiveness of Tumour Necrosis Factor-alpha Inhibitors in the Treatment of Plaque Psoriasis under Daily Life Conditions: Report from the Psoriasis Registry AustriaMartin Inzinger, Katharina Wippel-Slupetzky, Wolfgang Weger, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Plos One|June 20, 2025
Genomic profiling in hidradenitis suppurativa: InterOmics pipeline for DNA-RNA sequencing highlights HLA variants, keratin-associated mutations and extracellular matrix alterations as contributing factors to HS pathogenesisLucas André Cavalcanti Brandão, Ronald Rodrigues de Moura, Bruno Rodrigo Assunção, et al.
Archives of Dermatological Research|March 18, 2019
Successful intra-class switching among IL-17 antagonists: a multicentre, multinational, retrospective studyIrina Gasslitter, Natalia Kirsten, Matthias Augustin, et al.
The Journal of Allergy and Clinical Immunology|February 20, 2025
IL-36-driven pustulosis: Transcriptomic signatures match between generalized pustular psoriasis (GPP) and acute generalized exanthematous pustulosis (AGEP)Theresa Benezeder, Natalie Bordag, Johannes Woltsche, et al.
Nucleic Acids Research|January 15, 2021
Evidence for multi-copy Mega-NUMTs in the human genomeSabine Lutz-Bonengel, Harald Niederstätter, Jana Naue, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 16, 2025
Recommendations for the diagnostic work-up of cutaneous small vessel vasculitis - Position Statement of the European Academy of Dermatology and Venereology Vasculitis and Vasculopathy Task ForceErkan Alpsoy, Marzia Caproni, David A Wetter, et al.
The British Journal of Dermatology|October 12, 2025
Real-world evidence on palmoplantar pustulosis: patient characteristics, diagnostic challenges and predictive factors for treatment survival - a retrospective registry studyThomas Graier, Natalie Bordag, Wolfgang Weger, et al.
JAAD International|August 19, 2021
Effectiveness and clinical predictors of drug survival in psoriasis patients receiving apremilast: A registry analysisThomas Graier, Wolfgang Weger, Paul-Gunther Sator, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 12, 2023
Entwicklung der Patientencharakteristika und der Wirksamkeit der Biologika-Therapie bei Patienten des Österreichischen Psoriasis-Registers von 2004 bis 2022Thomas Graier, Wolfgang Salmhofer, Constanze Jonak, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 31, 2023
Evolution of characteristics and biologic treatment effectiveness in patients of the Austrian psoriasis registry from 2004-2022Thomas Graier, Wolfgang Salmhofer, Constanze Jonak, et al.
Acta Dermato-Venereologica|August 14, 2015
Survival and Effectiveness of Tumour Necrosis Factor-alpha Inhibitors in the Treatment of Plaque Psoriasis under Daily Life Conditions: Report from the Psoriasis Registry AustriaMartin Inzinger, Katharina Wippel-Slupetzky, Wolfgang Weger, et al.
Pageof 5